Role of the Fas/FasL pathway in HIV or SIV disease

Retrovirology

Volumn 6, Issue , 2009, Pages

  Poonia, Bhawna ^a   Pauza, C David ^a   Salvato, Maria S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MESSENGER RNA;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL DESTRUCTION; CELL KILLING; CROSS LINKING; CYTOTOXIC T LYMPHOCYTE; GENE ACTIVATION; GENE FUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; PATHOGENESIS; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; TH17 CELL; TISSUE DISTRIBUTION; UPREGULATION; VIRUS REPLICATION; ANIMAL; BIOLOGICAL MODEL; HAPLORHINI; HUMAN IMMUNODEFICIENCY VIRUS; PATHOGENICITY; PHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIGENS, CD95; CELL DEATH; FAS LIGAND PROTEIN; HAPLORHINI; HIV; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 71149112777     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-91     Document Type: Review

References (72)

1. Ho J, Moir S, Malaspina A, Howell ML, Wang W, DiPoto AC, O'Shea MA, Roby GA, Kwan R, Mican JM. Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms. Proc Natl Acad Sci USA 2006, 103:19436-19441. 10.1073/pnas.0609515103, 1748244, 17158796.
2. Mela CM, Steel A, Lindsay J, Gazzard BG, Gotch FM, Goodier MR. Depletion of natural killer cells in the colonic lamina propria of viraemic HIV-1-infected individuals. AIDS 2007, 21:2177-2182. 10.1097/QAD.0b013e3282f08b72, 18090044.
3. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol 2009, 9:235-245. 10.1038/nri2524, 19319142.
4. Dykhuizen M, Mitchen JL, Montefiori DC, Thomson J, Acker L, Lardy H, Pauza CD. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J Gen Virol 1998, 79(Pt 10):2461-2467.
5. Enders PJ, Yin C, Martini F, Evans PS, Propp N, Poccia F, Pauza CD. HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment. AIDS Res Hum Retroviruses 2003, 19:21-29. 10.1089/08892220360473934, 12581513.
6. Trimble LA, Lieberman J. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood 1998, 91:585-594.
7. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354. 10.1038/nature05115, 16921384.
8. Kaufmann DE, Kavanagh DG, Pereyra F, Zaunders JJ, Mackey EW, Miura T, Palmer S, Brockman M, Rathod A, Piechocka-Trocha A. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol 2007, 8:1246-1254. 10.1038/ni1515, 17906628.
9. Amarnath S, Dong L, Li J, Wu Y, Chen W. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25-T cells. Retrovirology 2007, 4:57. 10.1186/1742-4690-4-57, 2096626, 17688698.
10. Cao W, Jamieson BD, Hultin LE, Hultin PM, Detels R. Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression. AIDS Res Hum Retroviruses 2009, 25:183-191. 10.1089/aid.2008.0140, 19239357.
11. Kolte L, Gaardbo JC, Skogstrand K, Ryder LP, Ersboll AK, Nielsen SD. Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs. Clin Exp Immunol 2009, 155:44-52. 10.1111/j.1365-2249.2008.03803.x, 19016807.
12. Robbins GK, Spritzler JG, Chan ES, Asmuth DM, Gandhi RT, Rodriguez BA, Skowron G, Skolnik PR, Shafer RW, Pollard RB. Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. Clin Infect Dis 2009, 48:350-361. 10.1086/595888, 19123865.
13. Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, Mitsuyasu RT, Kilby JM. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 1999, 103:1391-1398. 10.1172/JCI5863, 408455, 10330421.
14. Brown KN, Wijewardana V, Liu X, Barratt-Boyes SM. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog 2009, 5:e1000413. 10.1371/journal.ppat.1000413, 2671605, 19424421.
15. Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev 2006, 8:88-97.
16. Badolato R. Immunological nonresponse to highly active antiretroviral therapy in HIV-infected subjects: is the bone marrow impairment causing CD4 lymphopenia?. Clin Infect Dis 2008, 46:1911-1912. 10.1086/588481, 18462176.
17. Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody MA, Ferrari G, Weinhold KJ, Miller SE. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J Virol 2008, 82:7700-7710. 10.1128/JVI.00605-08, 2493338, 18508902.
18. Herbeuval JP, Nilsson J, Boasso A, Hardy AW, Vaccari M, Cecchinato V, Valeri V, Franchini G, Andersson J, Shearer GM. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. AIDS 2009, 23:35-40. 10.1097/QAD.0b013e32831cb907, 19050384.
19. Miura Y, Koyanagi Y. Death ligand-mediated apoptosis in HIV infection. Rev Med Virol 2005, 15:169-178. 10.1002/rmv.462, 15765545.
20. Yang Y, Tikhonov I, Ruckwardt TJ, Djavani M, Zapata JC, Pauza CD, Salvato MS. Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J Virol 2003, 77:6700-6708. 10.1128/JVI.77.12.6700-6708.2003, 156176, 12767990.
21. Campbell GR, Pasquier E, Watkins J, Bourgarel-Rey V, Peyrot V, Esquieu D, Barbier P, de Mareuil J, Braguer D, Kaleebu P. The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J Biol Chem 2004, 279:48197-48204. 10.1074/jbc.M406195200, 15331610.
22. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375:497-500. 10.1038/375497a0, 7539892.
23. Zhang M, Li X, Pang X, Ding L, Wood O, Clouse KA, Hewlett I, Dayton AI. Identification of a potential HIV-induced source of bystander-mediated apoptosis in T-cells: Upregulation of TRAIL in primary Human Macrophages by HIV-1 Tat. J Biomed Sci 2001, 8:290-296. 10.1007/BF02256603, 11385301.
24. Lum JJ, Schnepple DJ, Badley AD. Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions. AIDS 2005, 19:1125-1133. 10.1097/01.aids.0000176212.16205.23, 15990565.
25. Muthumani K, Choo AY, Hwang DS, Premkumar A, Dayes NS, Harris C, Green DR, Wadsworth SA, Siekierka JJ, Weiner DB. HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation. Blood 2005, 106:2059-2068. 10.1182/blood-2005-03-0932, 1895138, 15928037.
26. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991, 87:1710-1715. 10.1172/JCI115188, 295273, 2022741.
27. Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992, 331-340. 10.1084/jem.175.2.331, 2119133, 1346269.
28. Wallace M, Pauza CD, Salvato MS. Macaque models for early immunosuppression and T cell loss during acute immunodeficiency virus infections. J Biol Regul Homeost Agents 2001, 15:304-307.
29. Gougeon ML, Colizzi V, Dalgleish A, Montagnier L. New concepts in AIDS pathogenesis. AIDS Res Hum Retroviruses 1993, 9:287-289. 10.1089/aid.1993.9.287, 8471320.
30. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995, 181:71-77. 10.1084/jem.181.1.71, 2191813, 7528780.
31. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med 1995, 1:129-134. 10.1038/nm0295-129, 7585008.
32. Gougeon ML. Chronic activation of the immune system in HIV infection: contribution to T cell apoptosis and V beta selective T cell anergy. Curr Top Microbiol Immunol 1995, 200:177-193.
33. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995, 373:444-448. 10.1038/373444a0, 7530337.
34. Lynch DH, Ramsdell F, Alderson MR. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995, 16:569-574. 10.1016/0167-5699(95)80079-4, 8579749.
35. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST, Marshak-Rothstein A. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995, 374:163-165. 10.1038/374163a0, 7533263.
36. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996, 70:199-206. 189805, 8523526.
37. Ji J, Cloyd MW. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression. Int Immunol 2009, 21:283-294. 10.1093/intimm/dxn146, 19208751.
38. Mitra D, Steiner M, Lynch DH, Staiano-Coico L, Laurence J. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996, 87:581-585. 10.1046/j.1365-2567.1996.510589.x, 1384136, 8675212.
39. Xu XN, Screaton GR, Gotch FM, Dong T, Tan R, Almond N, Walker B, Stebbings R, Kent K, Nagata S. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med 1997, 186:7-16. 10.1084/jem.186.1.7, 2198954, 9206992.
40. Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 1997, 89:1357-1363.
41. Algeciras A, Dockrell DH, Lynch DH, Paya CV. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J Exp Med 1998, 187:711-720. 10.1084/jem.187.5.711, 2212167, 9480981.
42. Boirivant M, Viora M, Giordani L, Luzzati AL, Pronio AM, Montesani C, Pugliese O. HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis. J Clin Immunol 1998, 18:39-47. 10.1023/A:1023235803948, 9475352.
43. Malhotra U, Huntsberry C, Holte S, Lee J, Corey L, McElrath MJ. CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression. Clin Immunol 2006, 119:95-102. 10.1016/j.clim.2005.11.010, 16403675.
44. Pauza C. HIV Persistence in Monocytes Leads to Pathogenesis and AIDS. Cellular Immunology 1988, 112:414-424. 10.1016/0008-8749(88)90310-3, 3281762.
45. Kharbanda M, McCloskey TW, Pahwa R, Sun M, Pahwa S. Alterations in T-cell receptor Vbeta repertoire of CD4 and CD8 T lymphocytes in human immunodeficiency virus-infected children. Clin Diagn Lab Immunol 2003, 10:53-58. 145262, 12522039.
46. Ren GL, Chen JP, Jia MM, Kou ZC, Liu S, Ma PF, Shao YM, Hong KX. [T cell receptor diversity of CD8(+) T lymphocytes and its association with viral load in individuals with HIV-1 infection]. Zhonghua Yu Fang Yi Xue Za Zhi 2009, 43:404-408.
47. Viau M, Veas F, Zouali M. Direct impact of inactivated HIV-1 virions on B lymphocyte subsets. Mol Immunol 2007, 44:2124-2134. 10.1016/j.molimm.2006.07.302, 17134757.
48. Chen W, Tang Z, Fortina P, Patel P, Addya S, Surrey S, Acheampong EA, Mukhtar M, Pomerantz RJ. Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways. Virology 2005, 334:59-73. 10.1016/j.virol.2005.01.014, 15749123.
49. Arokium H, Kamata M, Chen I. Virion-associated Vpr of HIV-1 triggers the activation of apoptotic events and enhances Fas induced apoptosis in human T cells. J Virol 2009, 83:11283-97. 10.1128/JVI.00756-09, 19692467.
50. Sasaki Y, Ami Y, Nakasone T, Shinohara K, Takahashi E, Ando S, Someya K, Suzaki Y, Honda M. Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus. Clin Exp Immunol 2000, 122:381-389. 10.1046/j.1365-2249.2000.01327.x, 1905812, 11122244.
51. Iida T, Ichimura H, Shimada T, Ibuki K, Ui M, Tamaru K, Kuwata T, Yonehara S, Imanishi J, Hayami M. Role of apoptosis induction in both peripheral lymph nodes and thymus in progressive loss of CD4+ cells in SHIV-infected macaques. AIDS Res Hum Retroviruses 2000, 16:9-18. 10.1089/088922200309557, 10628812.
52. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434:1093-1097. 10.1038/nature03501, 15793563.
53. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434:1148-1152.
54. Kader M, Wang X, Piatak M, Lifson J, Roederer M, Veazey R, Mattapallil JJ. Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol 2009, 2:439-449. 10.1038/mi.2009.90, 19571800.
55. Arnoult D, Petit F, Lelievre JD, Lecossier D, Hance A, Monceaux V, Hurtrel B, Ho Tsong Fang R, Ameisen JC, Estaquier J. Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression. Cell Death Differ 2003, 10:1240-1252. 10.1038/sj.cdd.4401289, 14576776.
56. Viollet L, Monceaux V, Petit F, Ho Tsong Fang R, Cumont MC, Hurtrel B, Estaquier J. Death of CD4+ T cells from lymph nodes during primary SIVmac251 infection predicts the rate of AIDS progression. J Immunol 2006, 177:6685-6694.
57. Li Q, Smith AJ, Schacker TW, Carlis JV, Duan L, Reilly CS, Haase AT. Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J Immunol 2009, 183:1975-1982. 10.4049/jimmunol.0803222, 19596987.
58. Wallace M, Waterman PM, Mitchen JL, Djavani M, Brown C, Trivedi P, Horejsh D, Dykhuizen M, Kitabwalla M, Pauza CD. Lymphocyte activation during acute simian/human immunodeficiency virus SHIV(89.6PD) infection in macaques. J Virol 1999, 73:10236-10244. 113077, 10559340.
59. Aillet F, Masutani H, Elbim C, Raoul H, Chene L, Nugeyre MT, Paya C, Barre-Sinoussi F, Gougerot-Pocidalo MA, Israel N. Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines. J Virol 1998, 72:9698-9705. 110479, 9811703.
60. Fernandez Larrosa PN, Croci DO, Riva DA, Bibini M, Luzzi R, Saracco M, Mersich SE, Rabinovich GA, Martinez Peralta L. Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway. Retrovirology 2008, 5:19. 10.1186/1742-4690-5-19, 2276517, 18261236.
61. Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 1998, 102:79-87. 10.1172/JCI2691, 509068, 9649560.
62. Chavan SJ, Tamma SL, Kaplan M, Gersten M, Pahwa SG. Reduction in T cell apoptosis in patients with HIV disease following antiretroviral therapy. Clin Immunol 1999, 93:24-33. 10.1006/clim.1999.4770, 10497008.
63. Nisihara T, Ushio Y, Higuchi H, Kayagaki N, Yamaguchi N, Soejima K, Matsuo S, Maeda H, Eda Y, Okumura K, Yagita H. Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: structural insights into Fas/Fas ligand interaction. J Immunol 2001, 167:3266-3275.
64. Salvato MS, Yin CC, Yagita H, Maeda T, Okumura K, Tikhonov I, Pauza CD. Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. Clin Dev Immunol 2007, 2007:93462. 2248700, 18317535.
65. Poonia B, Salvato MS, Yagita H, Maeda T, Okumura K, Pauza CD. Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus. Blood 2009, 114:1196-204. 10.1182/blood-2009-02-202655, 19498020.
66. Villinger F, Folks TM, Lauro S, Powell JD, Sundstrom JB, Mayne A, Ansari AA. Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates. Immunol Lett 1996, 51:59-68. 10.1016/0165-2478(96)02556-4, 8811346.
67. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, McClure HM, Staprans SI, Feinberg MB. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003, 18:441-452. 10.1016/S1074-7613(03)00060-8, 12648460.
68. Yin C, Wu MS, Pauza CD, Salvato MS. High major histocompatibility complex-unrestricted lysis of SIV envelope-expressing cells predisposes macaques to rapid AIDS progression. J Virol 1999, 73:3692-3701. 104144, 10196261.
69. Monceaux V, Estaquier J, Fevrier M, Cumont MC, Riviere Y, Aubertin AM, Ameisen JC, Hurtrel B. Extensive apoptosis in lymphoid organs during primary SIV infection predicts rapid progression towards AIDS. Aids 2003, 17:1585-1596. 10.1097/00002030-200307250-00002, 12853740.
70. Meythaler M, Martinot A, Wang Z, Pryputniewicz S, Kasheta M, Ling B, Marx PA, O'Neil S, Kaur A. Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection. J Virol 2009, 83:572-583. 10.1128/JVI.01715-08, 2612394, 18987149.
71. Vieillard V, Le Grand R, Dausset J, Debre P. A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques. Proc Natl Acad Sci USA 2008, 105:2100-2104. 10.1073/pnas.0711629105, 2542869, 18234855.
72. Geiben-Lynn R, Greenland JR, Frimpong-Boateng K, van Rooijen N, Hovav AH, Letvin NL. CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses. Blood 2008, 112:4585-4590. 10.1182/blood-2008-06-165803, 18784371.